Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 1.07.

  • Puma Biotechnology's Asset Utilization Ratio fell 684.85% to 1.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.07, marking a year-over-year decrease of 684.85%. This contributed to the annual value of 1.04 for FY2024, which is 27.08% down from last year.
  • As of Q3 2025, Puma Biotechnology's Asset Utilization Ratio stood at 1.07, which was down 684.85% from 1.22 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Asset Utilization Ratio high stood at 1.27 for Q2 2023, and its period low was 0.94 during Q1 2022.
  • Over the past 5 years, Puma Biotechnology's median Asset Utilization Ratio value was 1.09 (recorded in 2023), while the average stood at 1.11.
  • As far as peak fluctuations go, Puma Biotechnology's Asset Utilization Ratio skyrocketed by 3079.83% in 2023, and later tumbled by 1771.49% in 2024.
  • Quarter analysis of 5 years shows Puma Biotechnology's Asset Utilization Ratio stood at 1.12 in 2021, then rose by 6.27% to 1.19 in 2022, then decreased by 8.63% to 1.09 in 2023, then fell by 2.18% to 1.06 in 2024, then increased by 0.37% to 1.07 in 2025.
  • Its Asset Utilization Ratio was 1.07 in Q3 2025, compared to 1.22 in Q2 2025 and 1.14 in Q1 2025.